Takeda Pharmaceutical Co Ltd

ASSETMARK, INC TAK

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/23/2026

Shares

156,120

Value ($000)

2,434

Weight

0.0%

2019 Q4 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/23/2026	2,434	0.0%	156,120	12/31/2025
2025 Q3	11/6/2025	1,789	0.0%	122,218	9/30/2025
2025 Q2	8/4/2025	1,480	0.0%	95,720	6/30/2025
2025 Q1	5/6/2025	1,287	0.0%	86,539	3/31/2025
2024 Q4	2/6/2025	1,141	0.0%	86,167	12/31/2024
2024 Q3	11/1/2024	1,152	0.0%	80,982	9/30/2024
2024 Q2	8/13/2024	990	0.0%	76,482	6/30/2024
2024 Q1	5/7/2024	1,050	0.0%	75,592	3/31/2024
2023 Q4	2/9/2024	1,024	0.0%	71,728	12/31/2023
2023 Q3	10/27/2023	1,107	0.0%	71,535	9/30/2023
2023 Q2	8/11/2023	1,124	0.0%	71,534	6/30/2023
2023 Q1	5/5/2023	1,097	0.0%	66,588	3/31/2023
2022 Q4	2/10/2023	233	0.0%	14,940	12/31/2022
2022 Q3	11/1/2022	180	0.0%	13,850	9/30/2022
2022 Q2	8/3/2022	181	0.0%	12,862	6/30/2022
2022 Q1	5/13/2022	198	0.0%	13,822	3/31/2022
2021 Q4	2/14/2022	173	0.0%	12,670	12/31/2021
2021 Q3	11/12/2021	197	0.0%	12,003	9/30/2021
2020 Q4	2/10/2021	1,129	0.0%	62,049	12/31/2020
2020 Q3	11/13/2020	667	0.0%	37,369	9/30/2020
2020 Q2	8/11/2020	506	0.0%	28,235	6/30/2020
2020 Q1	5/12/2020	294	0.0%	19,392	3/31/2020
2019 Q4	2/11/2020	1,783	0.0%	90,378	12/31/2019